CorVel Co. (NASDAQ:CRVL – Get Free Report) Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total transaction of $1,187,178.00. Following the transaction, the director now directly owns 118,213 shares in the company, valued at approximately $13,758,811.07. The trade was a 7.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
CorVel Trading Down 5.0 %
NASDAQ CRVL opened at $108.54 on Friday. The firm’s fifty day simple moving average is $123.39 and its two-hundred day simple moving average is $113.57. CorVel Co. has a 12-month low of $76.20 and a 12-month high of $128.61. The firm has a market capitalization of $5.57 billion, a P/E ratio of 63.85 and a beta of 1.16.
CorVel (NASDAQ:CRVL – Get Free Report) last released its quarterly earnings results on Tuesday, February 4th. The business services provider reported $0.46 earnings per share (EPS) for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.
Hedge Funds Weigh In On CorVel
Wall Street Analysts Forecast Growth
Separately, StockNews.com lowered shares of CorVel from a “buy” rating to a “hold” rating in a report on Tuesday, February 18th.
Check Out Our Latest Report on CorVel
CorVel Company Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Featured Articles
- Five stocks we like better than CorVel
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- DuPont’s Electronics Spinoff: The Start of Something Big
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.